OncoSec Medical Incorporated (NASDAQ:ONCS) traded at $3.90 at last check on Wednesday, November 23, made a downward move of -0.51% on its previous day’s price.
Looking at the stock we see that its previous close was $3.92 and the beta (5Y monthly) reads 1.90 with the day’s price range being $3.91 – $6.4999. In terms of its 52-week price range, ONCS has a high of $34.76 and a low of $3.35. The company’s stock has lost about -55.68% over that past 30 days.
OncoSec Medical Incorporated has a market cap of $8.04 million and is expected to release its quarterly earnings report on Dec 11, 2020. Estimates by analysts give the company expected earnings per share (EPS) of -$0.24, with the EPS growth for the year raised at -$0.9 for 2022 and -$0.66 for next year. These figures represent 34.30% and 26.70% growth in EPS for the two years respectively.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the ONCS stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the OncoSec Medical Incorporated (ONCS) stock as a Hold, while 0 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Hold and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -38.22% off its SMA20 and -56.60% from its 50-day simple moving average. The RSI (14) is pointing at 28.57 while the volatility over the past week is 33.48% and jumps to 18.63% over the past one month. The beta value is 1.64, while the average true range (ATR) is currently pointing at 1.02. The average price target for the stock over the next 12 months is $110.00, with the estimates having a low of $110.00 and a high of $110.00. These price ends are -2720.51% and -2720.51% off the today’s price level respectively, although investors could be excited at the prospect of a -2720.51% if the ONCS share price touches on the median price of $110.00.
Coming back to OncoSec Medical Incorporated (NASDAQ:ONCS), we note that the average 3-month trading volume was 277.87K, while that of the preceding 10-day period stands at 1.8 million. Current shares outstanding are 1.79 million.
The insiders hold 0.10% of the company’s shares while institutions hold 13.90%. The data shows that short shares as of Oct 13, 2022, stood at 63230.0 at a short ratio of 3.4. This represents a 0.16% short interest in shares outstanding on Oct 13, 2022. Shares short fall in October from the previous month at 81330.0. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -81.43% down in year-to-date price movement.